Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intravenous magnesium administration in bronchial asthma].

S P Hauser1, P H Braun

  • 1Zürcher Hochgebirgsklinik, Clavadel-Davos.

Schweizerische Medizinische Wochenschrift
|November 18, 1989
PubMed
Summary

Intravenous magnesium aspartate hydrochloride improved lung function in most asthma patients. This magnesium infusion significantly enhanced forced vital capacity, forced expiratory volume, and peak expiratory flow in asthmatic individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transient thrombopoietin peak after liver transplantation for end-stage liver disease.

British journal of haematology·2001
Same author

Autosomal dominant inheritance of scapuloiliac dysostosis.

American journal of medical genetics·2001
Same author

Quality assurance in thrombapheresis.

Transfusion science·2000
Same author

Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery.

The International journal of artificial organs·1999
Same author

Effects of myelotoxic agents on cytokine production in murine long-term bone marrow cultures.

Stem cells (Dayton, Ohio)·1998
Same author

Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.

European neurology·1998

Area of Science:

  • Respiratory Medicine
  • Clinical Pharmacology

Context:

  • Asthma is a chronic respiratory disease characterized by airway inflammation and hyperreactivity.
  • Current treatments aim to manage symptoms and prevent exacerbations, but novel therapeutic approaches are continually sought.

Purpose:

  • To investigate the efficacy of intravenous magnesium aspartate hydrochloride (MgAHCl) in improving lung function parameters in hospitalized asthma patients.
  • To assess the impact of MgAHCl on forced vital capacity (FVC), forced expiratory volume at 1 second (FEV1), and peak expiratory flow (PEF).

Summary:

  • A study involving 17 asthmatic inpatients evaluated the effects of intravenous MgAHCl.
  • Patients with initial FVC ≤ 90% showed significant improvements: FVC increased by 56-61% (p<0.01), FEV1 by 40-44% (p<0.02), and PEF by 45-56% (p<0.02).
  • No significant changes in respiratory resistance were observed, but average serum magnesium levels increased during and after infusion.

Impact:

  • Intravenous magnesium administration demonstrates potential as a valuable adjunct therapy for asthma management.
  • MgAHCl may offer cardioprotective benefits and reduce bronchial hyperreactivity, contributing to improved outcomes in asthmatic patients.

Related Experiment Videos